Metraipolis › archive › dc_c505ad17ff24
Multi-omics profiling unravel the immune landscape diversity by prognostic signatures of immunotherapy response in triple-negative breast cancer — Europe PMC PMID:41488652
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41488652
- DOI
- 10.3389/fimmu.2025.1735893
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-07T13:24:48.858Z
- SHA-256 of the archived text
2a8f9f32437ebf603d5dced9f5e0d44e212d82bc6491666e942e020626ddbd10- Stable URL of this page
https://metraipolis.com/documento/dc_c505ad17ff24
How to cite
Multi-omics profiling unravel the immune landscape diversity by prognostic signatures of immunotherapy response in triple-negative breast cancer — Europe PMC PMID:41488652 — Europe PMC (en), https://europepmc.org/article/MED/41488652 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_c505ad17ff24 (Metraipolis archive dc_c505ad17ff24, sha256 2a8f9f32437ebf603d5dced9f5e0d44e212d82bc6491666e942e020626ddbd10)
BibTeX
@misc{dcc505ad17ff24,
title = {Multi-omics profiling unravel the immune landscape diversity by prognostic signatures of immunotherapy response in triple-negative breast cancer — Europe PMC PMID:41488652},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41488652},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_c505ad17ff24; sha256 2a8f9f32437ebf603d5dced9f5e0d44e212d82bc6491666e942e020626ddbd10},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41488652. Agents can read the archived copy with the MCP tool read_document.